山河药辅通过美国FDA现场检查

Group 1 - The company, Shanhe Pharmaceutical (300452.SZ), has successfully passed the FDA on-site inspection as confirmed by the issued Establishment Inspection Report (EIR) [1] - The completion of the inspection marks a significant milestone for the company in its compliance with U.S. regulatory standards [1] - This successful inspection may enhance the company's credibility and potential for market expansion in the U.S. pharmaceutical sector [1]